Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial
Top Cited Papers
- 6 May 2016
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 17 (6), 747-756
- https://doi.org/10.1016/s1470-2045(16)00111-x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Upfront Androgen Deprivation Therapy With Salvage Radiation May Improve Biochemical Outcomes in Prostate Cancer Patients With Post-Prostatectomy Rising PSAInternational Journal of Radiation Oncology*Biology*Physics, 2012
- The natural history of metastatic progression in men with prostate‐specific antigen recurrence after radical prostatectomy: long‐term follow‐upBJU International, 2011
- Salvage Radiotherapy for Patients with PSA Relapse Following Radical Prostatectomy: Issues and ChallengesCancer Research and Treatment, 2010
- Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical TrialJournal of Urology, 2009
- Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical ProstatectomyJama-Journal Of The American Medical Association, 2008
- Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Preliminary Results of GETUG-01Journal of Clinical Oncology, 2007
- Predominant Treatment Failure in Postprostatectomy Patients Is Local: Analysis of Patterns of Treatment Failure in SWOG 8794Journal of Clinical Oncology, 2007
- Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical ProstatectomyJournal of Clinical Oncology, 2007
- Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized DefinitionJournal of Clinical Oncology, 2006
- Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials GroupEuropean Journal Of Cancer, 2005